Could Immunotherapy Become The New Standard After Surgery For Stomach And Esophageal Cancer?

Could Immunotherapy Become The New Standard After Surgery For Stomach And Esophageal Cancer?

Credits: Canva

Text

Updated Jul 24, 2025 | 06:00 AM IST

SummaryJack Georgakis, diagnosed with aggressive gastroesophageal junction cancer, recovered through a groundbreaking treatment combining chemotherapy with immunotherapy. A global clinical trial showed this approach significantly reduces recurrence and improves survival, offering renewed hope against gastric and oesophageal cancers. This innovative method could transform future cancer treatment and save millions of lives worldwide.

End of Article